fda tirzepatide news - Search News

Eli Lilly's tirzepatide is off FDA's shortage list

Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

NBC News on MSN · 1d

Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.

WKBW · 19h

FDA is reconsidering its decision to take tirzepatide off its drug shortage list

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications Mounjaro and Zepbound, the FDA said in a recent court filing.

Monthly Prescribing Reference59m

FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.

22h

Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

FDA To Reassess Ban On Cheaper, Compounded Versions of Eli Lilly Weight Loss Drugs

The FDA resolved the shortage of Eli Lilly's tirzepatide, but may revisit allowing compounding pharmacies to make copies, ...

2don MSN

FDA Reversal on Knockoff GLP-1 Drugs Brings Confusion, and Few Answers

A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results